Bristol-Myers Squibb Aktie
54,59
EUR
+1,25
EUR
+2,34
%
58,45
USD
+1,65
USD
+2,90
%
Bristol-Myers Squibb Aktie Analyse
05.05.17 | Bristol-Myers Squibb Underperform | BMO Capital Markets | |
27.10.14 | Bristol-Myers Squibb Sell | MKM Partners | |
25.01.08 | Bristol-Myers Squibb sell | Goldman Sachs Group Inc. | |
05.09.07 | Bristol-Myers Squibb sell | Goldman Sachs Group Inc. | |
28.09.06 | Bristol-Myers Squibb verkaufen | Wertpapier | |
09.08.06 | Bristol-Myers Squibb sell | A.G. Edwards & Sons | |
14.10.05 | Bristol-Myers Squibb reduce | Jyske Bank | |
29.07.05 | Bristol-Myers Squibb reduce | Jyske Bank | |
Werbung
|
|||
15.07.05 | Bristol-Myers Squibb reduce | Jyske Bank | |
17.06.05 | Bristol-Myers Squibb reduce | Jyske Bank | |
23.05.05 | Bristol-Myers Squibb underweight | Prudential Financial | |
23.05.05 | Bristol-Myers Squibb underweight | Prudential Financial | |
21.03.05 | Bristol-Myers Squibb Underweight | JP Morgan |